EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer

Seiji Mabuchi, Tadashi Kimura

Chemotherapy Research and Practice · 2011

DOI: 10.1155/2011/963159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemotherapy Research and Practice, 2011. Verfasst von Seiji Mabuchi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the recent advances in the management of cervical cancer using cisplatin-based concurrent chemoradiotherapy, substantial treatment failure still occurs, especially in advanced-stage patients and early-stage cervical cancer patients with high-risk prognostic factors. Therefore, efforts to further improve the survival and quality of life of these patients are necessary. Nedaplatin (cis-diammine-glycoplatinum), a derivative of cisplatin, was developed with the aim of producing a treatment with a similar effectiveness to cisplatin but decreased renal and gastrointestinal toxicities. Based on the promising results of preclinical studies, the clinical efficacy of nedaplatin as a radiosensitizing agent was evaluated in patients with cervical cancer. Retrospective analysis of nedaplatin-based concurrent chemoradiotherapy (CCRT) against cervical cancer suggested that nedaplatin-based CCRT can be considered as an alternative to cisplatin-based CCRT in both early-stage and advanced-stage cervical cancer patients. However, due to the lack of a randomized controlled study, nedaplatin-based CCRT has not been convincingly proven to be clinically effective in patients with cervical cancer. Further investigations in randomized controlled trials are therefore needed.

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.

Zitieren

APA

Mabuchi, S., & Kimura, T. (2011). Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer. Chemotherapy Research and Practice. https://doi.org/10.1155/2011/963159

Vancouver

Mabuchi S, Kimura T. Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer. Chemotherapy Research and Practice. 2011. doi:10.1155/2011/963159

BibTeX
@article{Mabuchi2011,
  author = {Mabuchi, Seiji and Kimura, Tadashi},
  title = {Nedaplatin: A Radiosensitizing Agent for Patients with Cervical Cancer},
  journal = {Chemotherapy Research and Practice},
  year = {2011},
  doi = {10.1155/2011/963159}
}
Kostenlos starten →